Summary
SpectraCure AB (SpectraCure) is a healthcare technology company that develops different methods for treatment planning and laser light dose management for cancer treatment. The company develops and therapy system (PDT) commercializes photodynamic with IDOSE for tumors. Its IDOSE platform allows tomographic mapping and controls the interstitial PDT treatment which is used for accurate dosimetry of internal tumors and to avoid damage to healthy tissue. SpectraCure’s IDOSE can also perform real-time adjustments to the dose plan covering the different parts of the target tissue. The company sponsors multicentre phase l/ll clinical trial for recurrent prostate cancer. SpectraCure is headquartered in Lund, Sweden.
SpectraCure AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
                     
                                   '
                        
Table of Contents
Table of Contents  2
List of Tables  3
List of Figures  4
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
SpectraCure AB, Medical Devices Deals, 2010 to YTD 2016  9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
SpectraCure AB, Pharmaceuticals & Healthcare, Deal Details  11
Partnerships  11
SpectraCure Partners with Princess Margaret Hospital  11
SpectraCure Enters into Agreement with Larix  12
Equity Offering  13
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants  13
SpectraCure AB - Key Competitors  14
Key Employees  15
Locations And Subsidiaries  16
Head Office  16
Appendix  17
Methodology  17
About GlobalData  17
Contact Us  17
Disclaimer  17
List of Tables
SpectraCure AB, Pharmaceuticals & Healthcare, Key Facts  1
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
SpectraCure AB, Deals By Therapy Area, 2010 to YTD 2016  8
SpectraCure AB, Medical Devices Deals, 2010 to YTD 2016  9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
SpectraCure Partners with Princess Margaret Hospital  11
SpectraCure Enters into Agreement with Larix  12
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants  13
SpectraCure AB, Key Competitors  14
SpectraCure AB, Key Employees  15
List of Figures
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  1
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  1
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  1
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  1
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
SpectraCure AB, Medical Devices Deals, 2010 to YTD 2016  9